Cocrystal Pharma (COCP) Investor Presentation - Slideshow

C@CRYSTAL Potent antivirals to combat some of the most serious diseases facing humanity November 2022 Nasdaq: COCP www.cocrystalpharma.com 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the market opportunities for the treatment of acute and chronic viral diseases which are the focus of our programs; the development pipeline; our technology platform's ability to produce viable drug candidates ...